Indo-MIM's IPO saw 1.11 times subscription on its first day, driven by strong non-institutional investor demand. The ₹4,312 crore public issue will remain open until July 27, with the company aiming to use proceeds primarily to reduce its debt burden.
Detailed Coverage
The initial public offering (IPO) of Indo-MIM, a significant player in the metal injection molding sector, opened for public subscription on July 23, 2026. By the end of the first day, the total issue was subscribed 1.11 times, reflecting a varied response across different investor categories.
Non-institutional investors, which include high-net-worth individuals and corporate entities, led the activity with 2.95 times subscription. Within this group, demand was particularly notable for bids between ₹2 lakh and ₹10 lakh, which were subscribed 3.53 times. In contrast, retail individual investors showed a more cautious approach, subscribing to 0.85 times of their allocated quota. Qualified institutional buyers, who typically place their bids during the final days of the offering period, recorded a subscription level of 0.17 times on the opening day.
The IPO consists of a fresh issue of shares worth ₹500 crore alongside an offer-for-sale amounting to approximately ₹3,812 crore, based on the upper price band of ₹485 per share. A major focus of this offering is the company's capital allocation strategy, as it intends to use ₹400 crore of the fresh issue proceeds to pay down its existing debt. The remaining funds are planned for general corporate activities.
Financially, the company reported revenue from operations of ₹4,193 crore for the fiscal year 2026, marking a 25.9% increase compared to the previous year. The adjusted profit after tax for the same period was ₹611.6 crore. Analysts have highlighted the company’s operating profit margin of 25.5% and a return on capital employed of 20.8%. At the upper price band of ₹485, the issue is valued at a P/E multiple of approximately 39.2x to 45x based on FY26 earnings. Several brokerage houses have issued a subscribe rating, citing the company's international manufacturing presence and technical capabilities, though some noted the valuation reflects a premium.
Investors should note that the bidding window remains open until July 27, 2026, with the final allotment status and listing on the BSE and NSE expected by July 30, 2026. The key monitorable for shareholders will be the company’s ability to reduce its debt as planned and maintain its profit margins while scaling operations. The performance of the institutional category on the final days of the IPO will also be a critical factor in determining the overall demand for the issue.